Astrana Health, Inc.
corporate_fare Company Profile
Astrana Health, Inc. (NASDAQ:ASTH) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 15 items for ASTH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-10, rated 8/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for ASTH spans 10-Q, 8-K, DEF 14A, S-3ASR.
Recent high-impact activity:
- Astrana Health Q2 Revenue Jumps 49% to $972.5M, but Lingering Material Weakness Tempers the Quarter
- Astrana Health Q2 Revenue Misses, But EPS Crushes Estimates and Guidance Raised
- Astrana Health Q2 Revenue Surges 49%, Full-Year Adjusted EBITDA Guidance Raised
- Astrana Health ACOs Generate $120.4M in Shared Savings, Validating Value-Based Model
- Astrana Health ACOs Deliver $120.4M in Gross Shared Savings for 2024 Performance Year
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for ASTH, detected from its recent SEC filings · based on capital-structure filings through 2026-03-30.
Employee Stock Purchase Plan (ESPP) Registration · Potential Future Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →